| Titre : | Erectile dysfunction in Type 1 and Type 2 diabetics in Italy. (2000) |
| Auteurs : | D. FEDELE ; A. BORTOLOTTI ; L. CHATENOUD ; E. COLLI ; C. COSCELLI ; M. LANDONI ; M. LAVEZZARI ; F. PARAZZINI ; F. SANTEUSANIO ; Direzione Medica. Pharmacia & Upjohn Italia. Milano. ITA ; Gruppo Italiano Studio Deficit Erretile nei Diabetici. ITA ; Istituto'Mario Negri'Milano. ITA |
| Type de document : | Article |
| Dans : | International journal of epidemiology (vol. 29, n° 3, 2000) |
| Pagination : | 524-531 |
| Langues: | Anglais |
| Mots-clés : | Diabète insulinodépendant ; Diabète non insulinodépendant ; Complication ; Etude comparée ; Homme ; Glande endocrine [pathologie] ; Immunopathologie ; Maladie autoimmune |
| Résumé : | [BDSP. Notice produite par INIST pT7JrR0x. Diffusion soumise à autorisation]. Background Several studies reported data on the increased risk of erectile dysfunction (ED) in populations of diabetic men, but few presented data separately for Type 1 and Type 2 subjects. No comparison data for these diabetic subgroups are available with regard to risk factors for ED. Methods Eligible for the study were men aged 20-69 years with a diagnosis of insulin-dependent (Type 1) or non-insulin-dependent (Type 2) diabetes who were observed on randomly selected days in 178 diabetes centres in Italy. Erectile dysfunction was defined as a failure to achieve and maintain an erection sufficient for satisfactory sexual performance. Results The study population consisted of 1383 Type 1 and 8373 Type 2 men. The prevalence of ED increased with age for both groups. After taking into account the effect of age Type 2 men (37/100 men) tend to report ED less frequently than Type 1 men (51/100 men). A significant positive relationship was reported between ED and poor metabolic control and smoking for both Type 1 and Type 2 men, whereas high body mass index (BMI) increased only the risk of ED in Type 1 cases. Conclusions The study offers a quantitative estimate of the prevalence of ED and its main risk factors in Type 1 and Type 2 diabetic subgroups. |

